ArticleCNS neuroscience & therapeutics2019

The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia.

Marta De Felice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.